InspireMD, Inc. (NSPR) Reports Q4 Loss, Tops Revenue Estimates
InspireMD (NSPR) delivered earnings and revenue surprises of 5% and 6.50%, respectively, for the quarter ended December 2024. Do the…
2,560€
Echtzeit-Aktienkurs INSPIREMD 1/18 DL-,0001
Bid:
Ask:
Nachrichten zur INSPIREMD 1/18 DL-,0001 Aktie
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIAMI, Nov. 08, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent…
[Latest] Global Embolic Protection Device Market Size/Share Worth USD 3,562.2 Million by 2033 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…
InspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript
…
InspireMD Inc. (NSPR) Q1 2024 Earnings Call Transcript
…
InspireMD Inc. (NSPR) Q4 2023 Earnings Call Transcript
…